Table 3

Logistic regression analysis: associations between the clinical profiles and ‘rEF at second LVEF assessment’

UnivariableMultivariable
OR95% CIP valueOR95% CIP value
Age0.9880.978 to 0.9990.0280.9740.953 to 0.9950.016
Male gender1.6101.157 to 2.2420.0050.9980.505 to 1.9710.995
Body mass index0.9480.909 to 0.9880.0120.9330.865 to 1.0070.073
Systolic blood pressure0.9990.994 to 1.0040.666
Heart rate1.0161.010 to 1.022<0.0011.0120.996 to 1.0290.138
NYHA class III or IV1.2120.521 to 2.8190.655
Coronary artery disease2.0791.499 to 2.885<0.0012.1121.047 to 4.2590.037
Atrial fibrillation1.3170.958 to 1.8090.090
Hypertension1.3910.968 to 1.9970.074
Diabetes1.6091.168 to 2.2170.0041.5170.789 to 2.9150.211
Dyslipidaemia1.0480.739 to 1.4890.795
Chronic kidney disease1.5141.099 to 2.0840.0110.6940.342 to 1.4090.312
Anaemia1.7001.225 to 2.3600.0011.3780.699 to 2.7190.355
Hyperuricaemia2.4321.717 to 3.443<0.0011.3720.681 to 2.7620.376
Sleep-disordered breathing2.0991.526 to 2.888<0.0011.2121.007 to 1.4720.042
COPD1.2650.885 to 1.8100.197
Peripheral artery disease1.6060.993 to 2.5960.093
Smoking0.9480.691 to 1.3020.743
Alcohol0.6480.346 to 1.2120.175
Log BNP2.6001.864 to 3.628<0.0011.5430.845 to 2.8170.158
Log troponin I1.4651.222 to 1.756<0.0011.5741.055 to 2.3490.026
LVDd1.0801.059 to 1.101<0.0011.0691.030 to 1.109<0.001
LVEF0.9080.888 to 0.927<0.0010.9330.902 to 0.966<0.001
CLBBB2.7910.809 to 9.6340.104
QRS1.0081.001 to 1.0150.0260.9970.983 to 1.0110.662
QT0.9990.995 to 1.0030.559
QTc1.0081.003 to 1.0120.0021.0040.995 to 1.0130.409
RAS inhibitors0.7250.547 to 0.9360.0370.9310.472 to 1.3880.281
Mineral receptor antagonist0.9260.562 to 1.3240.463
Calcium channel blocker0.8930.647 to 1.2340.494
Beta blocker0.8920.413 to 1.3260.782
Diuretic2.8791.975 to 4.197<0.0012.2720.970 to 5.3200.414
Statin1.2970.943 to 1.7830.110
Digitalis1.5010.915 to 2.4620.108
ICD1.1800.744 to 1.8710.482
  • BNP, B-type natriuretic peptide; CLBBB, complete left bundle branch block; COPD, chronic obstructive pulmonary disease; HFpEF, heart failure with preserved LVEF; ICD, implantable cardiac defibrillator; LVDd, left ventricular end diastolic dimension; LVEF, left ventricular ejection fraction; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; RAS, renin–angiotensin–aldosterone system; rEF, reduced LVEF at second assessment.